About Institut Mérieux
Institut Mérieux is a Healthcare company based in Lyon (France) founded in 1897. Merieux family investments are managed by Institut Merieux. It operates on a Professional Services model. Institut Mérieux has raised $870.44 million across 1 funding round from investors including Exor. Institut Mérieux has completed 1 acquisition, including Biofire Diagnostics. Institut Mérieux offers products and services including Industrial Biology Solutions. Its focus areas include Biotechnology and Public Health Solutions.
Company details
Institut Mérieux is engaged in improving medicine and public health globally through expertise in industrial biology. Activities are centered on pushing the boundaries of biology to enhance patient care and consumer health. A global, interdisciplinary approach is adopted, involving network-based solutions without borders. Sectors served include healthcare with a focus on combating infectious diseases. Strategic guidance is provided to various subsidiary companies like bioMérieux and Transgene, fostering synergies across all areas.
- Headquarters Lyon, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website institut-merieux.com/en/home
- Social LinkedIn
- Legal Name Institut Mérieux
- Total Equity Funding$870.44M (USD)
in 1 rounds
- Latest Funding Round$870.44M (USD), Private Equity Round
Jul 2022
- Investors
- Investments & Acquisitions
Products & Services of Institut Mérieux
Institut Mérieux offers a comprehensive portfolio of products and services, including Industrial Biology Solutions.
Solutions in biology are provided for public health improvement.
Funding Insights of Institut Mérieux
Institut Mérieux has successfully raised a total of $870.44M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $870.44 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $870.44M
- Total Rounds 1
- Last Round Private Equity Round — $870.44M
- First Round $870.44M
(Jul 2022)
- Investors Count 1
All 1 funding rounds of Institut Mérieux with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $870.44M | Private Equity Round | – | Exor | – |
1 investors in total: 1 institutional.
Investors in Institut Mérieux
Institut Mérieux has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on health insurance companies and operates multiple industries | 1927 | exor.com | Amsterdam, Netherlands |
Investor details for Institut Mérieux
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Institut Mérieux
5 people are tracked at Institut Mérieux (1 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Michel Baguenault | Chief Executive Officer | Leadership |
Lilia Marchand | Assistante Du Directeur Général | Team |
Julien Deville | Financial Controller | Team |
Sandrine Flory | Directeur Financier | Team |
Pierre Chol | Directeur De Site | Team |
Complete people profiles for Institut Mérieux
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Institut Mérieux
Institut Mérieux has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biofire Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Molecular diagnostic solutions for genetic condition detection are provided. | biofiredx.com | Salt Lake, United States | 1990 | Dec 2021 | $485M |
Complete acquisition details for Institut Mérieux
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Institut Mérieux
3 dated milestones of Institut Mérieux across 125 years, from founding to its latest funding, stage changes and deals.
- Founded Institut Mérieux is founded.
- Acquisition Acquires Biofire Diagnostics.
- Funding First funding round of $870.4M.
Web traffic of Institut Mérieux
The website of Institut Mérieux (institut-merieux.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 2.4% vs previous month
Websites whose visitors overlap most with Institut Mérieux. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| merieux-partners.com | 100% | #3,884,488 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Institut Mérieux
Complete news archive for Institut Mérieux
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Institut Mérieux
Institut Mérieux was founded in 1897 and raised its 1st funding round 125 years after it was founded.
Institut Mérieux is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Institut Mérieux is a funded company, having raised a total of $870.44M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $870.44M, raised on Jul 2022.
Institut Mérieux is engaged in improving medicine and public health globally through expertise in industrial biology. Activities are centered on pushing the boundaries of biology to enhance patient care and consumer health. A global, interdisciplinary approach is adopted, involving network-based solutions without borders. Sectors served include healthcare with a focus on combating infectious diseases. Strategic guidance is provided to various subsidiary companies like bioMérieux and Transgene, fostering synergies across all areas.
Institut Mérieux offers Industrial Biology Solutions.
Institut Mérieux has made 1 acquisition, including Biofire Diagnostics.
Institut Mérieux has 1 investor. Key investors include Exor.
Institut Mérieux operates through Institut Mérieux.